Kazia Therapeutics
(NASDAQ) KZIA
Kazia Therapeutics Financials at a Glance
Market Cap
$83.21M
Revenue (TTM)
$2.52M
Net Income (TTM)
$50.68M
EPS (TTM)
$-6.82
P/E Ratio
-1.08
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$7.27
Volume
313
Open
$7.26
Price
$7.27
Volume
313
Open
$7.26
Previous Close
$7.27
Daily Range
$7.26 - $7.27
52-Week Range
$2.86 - $17.40
Dividend
$0.00
Beta (Volatility)
1.02 (Average)
Price
$7.27
Volume
313
Open
$7.26
Previous Close
$7.27
Daily Range
$7.26 - $7.27
52-Week Range
$2.86 - $17.40
KZIA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Kazia Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
John E. Friend, II, MD
Website
www.kaziatherapeutics.comHeadquarters
Sydney, NSW 2000, AU
KZIA Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-921%
Net Income Margin
-1130%
Return on Equity
-103%
Return on Capital
-39%
Return on Assets
-31%
Earnings Yield
-92.59%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$83.21M
Shares Outstanding
11.34M
Volume
313
Short Interest
0.00%
Avg. Volume
197.94K
Financials (TTM)
Gross Profit
$42.00K
Operating Income
$14.22M
EBITDA
$13.28M
Operating Cash Flow
$13.28M
Capital Expenditure
$0.00
Free Cash Flow
$13.28M
Cash & ST Invst.
$4.34M
Total Debt
$396.00K
Kazia Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
$83.21M
N/A
Market Cap/Employee
$9.25M
N/A
Employees
9
N/A
Net Income
$12.32M
-39.7%
EBITDA
$13.30M
-67.3%
Quarterly Fundamentals
Net Cash
$69.29M
+2063.2%
Accounts Receivable
$315.23K
+382.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$98.71K
-72.5%
Return on Assets
-31.35%
N/A
Return on Invested Capital
-38.87%
N/A
Free Cash Flow
$9.07M
-43.2%
Operating Cash Flow
$9.07M
-43.2%